Plasma exchange: An efective rescue therapy in critically ill patients with coronavirus disease 2019 infection

dc.contributor.author
Fernández Gómez, Javier
dc.contributor.author
Gratacós Ginès, Jordi
dc.contributor.author
Olivas, Pol
dc.contributor.author
Costa, Montserrat
dc.contributor.author
Nieto, Susana
dc.contributor.author
Mateo Ortega, Dolors
dc.contributor.author
Sánchez Rodríguez, María Belén
dc.contributor.author
Aguilar, Ferran
dc.contributor.author
Bassegoda, Octavi
dc.contributor.author
Ruiz, Pablo
dc.contributor.author
Caballol, Berta
dc.contributor.author
Pocurull, Anna
dc.contributor.author
Llach Roca, Joan
dc.contributor.author
Mustieles, M.Jesús
dc.contributor.author
Cid Vidal, Joan
dc.contributor.author
Reverter, Enric
dc.contributor.author
Toapanta, David
dc.contributor.author
Hernández Tejero, María
dc.contributor.author
Martínez, José Antonio
dc.contributor.author
Clària i Enrich, Joan
dc.contributor.author
Fernández, Carlos
dc.contributor.author
Mensa Pueyo, Josep
dc.contributor.author
Arroyo, Vicente
dc.contributor.author
Castro, Pedro
dc.contributor.author
Lozano Molero, Miguel
dc.date.issued
2021-03-18T16:55:41Z
dc.date.issued
2020-12-01
dc.date.issued
2021-03-18T16:55:42Z
dc.identifier
0090-3493
dc.identifier
https://hdl.handle.net/2445/175340
dc.identifier
709156
dc.identifier
32833695
dc.description.abstract
Objectives: Infection by severe acute respiratory syndrome coronavirus-2 can induce uncontrolled systemic inflammation and multiple organ failure. The aim of this study was to evaluate if plasma exchange, through the removal of circulating mediators, can be used as rescue therapy in these patients. Design: Single center case series. Setting: Local study. Subjects: Four critically ill adults with coronavirus disease 19 pneumonia that failed conventional interventions. Interventions: Plasma exchange. Two to six sessions (1.2 plasma volumes). Human albumin (5%) was used as the main replacement fluid. Fresh frozen plasma and immunoglobulins were administered after each session to avoid coagulopathy and hypogammaglobulinemia. Measurements and main results: Serum markers of inflammation and macrophage activation. All patients showed a dramatic reduction in inflammatory markers, including the main cytokines, and improved severity scores after plasma exchange. All survived to ICU admission. Conclusions: Plasma exchange mitigates cytokine storm, reverses organ failure, and could improve survival in critically ill patients with coronavirus disease 2019 infection.
dc.format
6 p.
dc.format
application/pdf
dc.format
application/pdf
dc.language
eng
dc.publisher
Lippincott, Williams & Wilkins
dc.relation
Reproducció del document publicat a: https://doi.org/10.1097/CCM.0000000000004613
dc.relation
Critical Care Medicine, 2020, vol. 48, num. 12, p. e1350-e1355
dc.relation
https://doi.org/10.1097/CCM.0000000000004613
dc.rights
cc-by-nc-nd (c) Fernández et al., 2020
dc.rights
http://creativecommons.org/licenses/by-nc-nd/3.0/es
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Biomedicina)
dc.subject
COVID-19
dc.subject
Plasma sanguini
dc.subject
COVID-19
dc.subject
Blood plasma
dc.title
Plasma exchange: An efective rescue therapy in critically ill patients with coronavirus disease 2019 infection
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion


Files in this item

FilesSizeFormatView

There are no files associated with this item.